트랜스덕션 인핸서 시약 시장 : 제품 유형별, 용도별, 표적 세포 유형별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Transduction Enhancer Reagents Market size was valued at US$ 120.8 Million in 2025, expanding at a CAGR of 8.4% from 2026 to 2033.

The transduction enhancer reagents market includes various chemicals, peptides, and formulation additives designed to improve the viral vector entry efficiency into target cells. The market offers a range of enhancer products, transduction kits, and other reagent formats for research applications. The application field is mainly driven by the need to increase lentiviral and retroviral delivery efficiency in challenging environments, such as reduced virus-cell interaction, antiviral restriction, and reduced transduction rates of primary and stem cell populations. Moreover, commercial examples, including LentiBOOST, TransDux, and LentiBlast, have been reported to address a growing need for reagents offering consistency, cell viability, and therapeutic development compatibility rather than enhanced infectivity. According to research published in 2025, the choice of enhancer could significantly impact the transduction outcome in a range of challenging cell types, indicating the market's role as an enabler of the viral gene transfer process.

Transduction Enhancer Reagents Market- Market Dynamics

Demand for Higher-Performance Transduction in Difficult Primary Cells

The key market driver is evolving from basic viral uptake to obtaining consistent gene delivery into cell types that are inherently difficult to transfect. The 2025 review noted that factors such as cell quality, vectors used, incubation conditions, and enhancers are interrelated drivers for effective transduction; although manufacturing methods continue to be unique for each specific product. Experimental proof confirms this need: according to the 2025 research on human retinal pigment epithelial cells, polybrene improved lentiviral transfection efficacy regardless of concentration, with optimal individual effect at a 10 μg/ml concentration and the combination of polybrene and protamine sulfate reaching 65.4% GFP-positive cells. Hence, suppliers of reagents are increasingly competing on performance predictability, cell compatibility, and process integration, and not just enhancement.

Transduction Enhancer Reagents Market- Segmentation Analysis:

The Global Transduction Enhancer Reagents Market is segmented on the basis of Product Type, Application, Target Cell Type, and Region.

By product type, product architecture is largely driven by the level of complexity of the transduction workflow. Standalone transduction enhancers offer the broadest scope of customization, with their chemistry modifiable per vector and cell type of choice, which LentiBOOST, TransDux, and LentiBlast represent through diverse mechanisms of action in enhancing viral-cell interaction. Transduction kits, meanwhile, represent a more integrated approach to viral transduction, either in terms of bundled components or standardized reagent formulation, thereby promoting reduced variability across an internal laboratory's process. The "Others" category subsumes additional specialized formats or reagent types that target specific vectors or cells. Consequently, the competitive landscape is increasingly characterized by a shift away from reagent abundance towards specialized formats that promote streamlining of the optimization process, in which translational end users would be especially invested.

By application, application-specific requirements are seen to drive demand. Cell therapy stands to benefit most from ex-vivo genetic modification of primary immune or stem cells, where high viability and functional readouts are paramount alongside high transduction efficiency, which a 2025 study on human and rhesus NK cell expansion and transduction highlights Poloxamer 407's potential in achieving 60% transduction rates on expanded rhesus NK cells with no reported decrement in viability or function. Gene therapies similarly involve introducing the therapeutic gene of interest into target cells, whereas vaccine development can potentially leverage viral vectors for encoded antigen production and immunogenicity. As such, cell and gene therapy applications are seen to have the most to gain from standardized, highly reproducible processes.

Transduction Enhancer Reagents Market- Geographical Insights

North America is primarily driven by the robustness of its commercial cell and gene therapy infrastructure and the adoption of transduction technologies by various therapeutic development pipelines. The U.S. regulatory environment continues to recognize the growing clinical relevance of genetically engineered cellular therapeutics in 2025, as evidenced by the delisting of REMS requirements for currently approved BCMA- and CD19-directed autologous CAR-T immunotherapies by the FDA in June. The FDA also approved an AAV-based gene therapy for spinal muscular atrophy in November 2025, which constitutes another regulatory milestone for the vector space. These trends have significant ramifications for enhancer suppliers, as the maturity of therapeutic platforms will increase the need for reproducible upstream cell-engineering processes, further bolstering the regional market for research grade and translational transduction reagents.

Europe constitutes a distinct opportunity due to its highly regulated environment for the development of advanced therapies, as well as the region's deep research expertise in the fields of gene and cell engineering. The EMA adopted its revised guideline pertaining to quality, non-clinical, and clinical requirements for investigational ATMPs with legal effect from July 2025. This highlights the need for controlled development and characterization of advanced therapies across the region. The European clinical development landscape was equally active in 2025, with an analysis published that year uncovering a total of 2,008 ATMP clinical trials listed across four databases, representing therapeutic approaches pertaining to gene, cell, and tissue-based therapeutics. Finally, European research institutions continue to probe the fundamental aspects of enhancer biology, such as recent findings from Inserm pertaining to Vectofusin and cyclosporin H's ability to overcome cellular restriction mechanisms. Collectively, this underscores the unique appeal of the European market for cell and gene editing technologies.

Transduction Enhancer Reagents Market- Competitive Landscape:

Competition is focused on diverse technical propositions, rather than a common standardized enhancer chemistry. Revvity is positioning its LentiBOOST technology as a non-cytotoxic solution spanning research and clinical applications, including challenging-to-transduce primary T cells, HSPCs, and NK cells. System Biosciences is targeting broad laboratory compatibility with its TransDux portfolio of reagents, whereas OZ Biosciences is differentiating its LentiBlast technology based on interactions at the membrane level, plus specialized products for stem cells and primary T cells. The competitive landscape is also moving beyond traditional reagents, with 2025 research identifying Poloxamer 407 as a new enhancer for NK cell transduction, whereas other studies are investigating combinations of transduction adjuvants and cellular restriction factor modulation. Competitive advantage is thus being driven by a focus on validated performance across cell types of clinical relevance and compatibility with standardized manufacturing.

Recent Developments:

In February 2025, Revvity announced that Abata Therapeutics had licensed LentiBOOST for engineered regulatory T-cell therapy development. The technology was selected to improve lentiviral transduction efficiency and vector copy number performance in Abata's engineered Treg program.

In June 2025, the University of New South Wales and collaborating researchers reported Poloxamer 407 as a transduction enhancer for lentiviral engineering of rhesus macaque and human NK cells. The study achieved transduction levels of up to 60% in expanded rhesus NK cells while maintaining reported cell viability and functionality.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRANSDUCTION ENHANCER REAGENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Thermo Fisher Scientific
• Takara Bio Inc.
• Bio-Techne
• System Biosciences (SBI)
• Miltenyi Biotec
• Applied Biological Materials
• OZ Biosciences
• Revvity
• Virongy
• BPS Bioscience
• komabiotech
• ABP Biosciences
• Merck KGaA (MilliporeSigma)
• Lonza Group
• Origene Technologies
• Others

GLOBAL TRANSDUCTION ENHANCER REAGENTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

• Transduction Enhancers
• Transduction Kits
• Others

GLOBAL TRANSDUCTION ENHANCER REAGENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

• Vaccines
• Gene Therapy
• Cell Therapy
• Others

GLOBAL TRANSDUCTION ENHANCER REAGENTS MARKET, BY TARGET CELL TYPE- MARKET ANALYSIS, 2020 - 2033

• Stem Cells
• Immune Cells
• Cancer Cells
• Others

GLOBAL TRANSDUCTION ENHANCER REAGENTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA

Table of Contents

1. Transduction Enhancer Reagents Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Transduction Enhancer Reagents Market Snippet by Product Type
  • 2.1.2. Transduction Enhancer Reagents Market Snippet by Application
  • 2.1.3. Transduction Enhancer Reagents Market Snippet by Target Cell Type
  • 2.1.4. Transduction Enhancer Reagents Market Snippet by Country
  • 2.1.5. Transduction Enhancer Reagents Market Snippet by Region
• 2.2. Competitive Insights

3. Transduction Enhancer Reagents Key Market Trends

• 3.1. Transduction Enhancer Reagents Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Transduction Enhancer Reagents Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Transduction Enhancer Reagents Market Opportunities
• 3.4. Transduction Enhancer Reagents Market Future Trends

4. Transduction Enhancer Reagents Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Transduction Enhancer Reagents Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Transduction Enhancer Reagents Market Landscape

• 6.1. Transduction Enhancer Reagents Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Transduction Enhancer Reagents Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
  • 7.1.2. Transduction Enhancers
  • 7.1.3. Transduction Kits
  • 7.1.4. Others

8. Transduction Enhancer Reagents Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
  • 8.1.2. Vaccines
  • 8.1.3. Gene Therapy
  • 8.1.4. Cell Therapy
  • 8.1.5. Others

9. Transduction Enhancer Reagents Market - By Target Cell Type

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Target Cell Type, 2025 & 2033 (%)
  • 9.1.2. Stem Cells
  • 9.1.3. Immune Cells
  • 9.1.4. Cancer Cells
  • 9.1.5. Others

10. Transduction Enhancer Reagents Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Transduction Enhancer Reagents Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Transduction Enhancer Reagents Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3.8. UK
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.8.5. UK Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3.9. France
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.9.5. France Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3.10. Italy
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.10.5. Italy Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3.11. Spain
    • 10.3.11.1. Overview
    • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.11.5. Spain Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3.12. The Netherlands
    • 10.3.12.1. Overview
    • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.12.5. The Netherlands Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Overview
    • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.13.5. Sweden Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3.14. Russia
    • 10.3.14.1. Overview
    • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.14.5. Russia Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3.15. Poland
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.15.5. Poland Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3.16. Denmark
    • 10.3.16.1. Overview
    • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.16.5. Denmark Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3.17. Rest of Europe
    • 10.3.17.1. Overview
    • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.17.5. Rest of the Europe Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Transduction Enhancer Reagents Key Manufacturers in Asia Pacific
  • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.6. APAC Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4.7. China
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.7.5. China Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4.8. India
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.8.5. India Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4.12. Indonesia
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.12.5. Indonesia Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4.13. Thailand
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.13.5. Thailand Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4.15. Taiwan
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.15.5. Taiwan Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4.16. Vietnam
    • 10.4.16.1. Overview
    • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.16.5. Vietnam Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4.17. Rest of APAC
    • 10.4.17.1. Overview
    • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.17.5. Rest of APAC Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
• 10.5. Latin America (LATAM)
  • 10.5.1. Overview
  • 10.5.2. Transduction Enhancer Reagents Key Manufacturers in Latin America
  • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.5.6. LATAM Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
• 10.6. Middle East and Africa (MEA)
  • 10.6.1. Overview
  • 10.6.2. Transduction Enhancer Reagents Key Manufacturers in Middle East and Africa
  • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.6.6. MEA Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.6.8. UAE
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.8.5. UAE Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.6.13. Iran
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.13.5. Iran Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.6.14. Qatar
    • 10.6.14.1. Overview
    • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.14.5. Qatar Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.6.15. Rest of MEA
    • 10.6.15.1. Overview
    • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.15.5. Rest of MEA Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Transduction Enhancer Reagents Industry

• 11.1. Competitive Benchmarking
  • 11.1.1. Competitive Dashboard
  • 11.1.2. Competitive Positioning
• 11.2. Company Profiles
  • 11.2.1. Thermo Fisher Scientific
  • 11.2.2. Takara Bio Inc.
  • 11.2.3. Bio-Techne
  • 11.2.4. System Biosciences (SBI)
  • 11.2.5. Miltenyi Biotec
  • 11.2.6. Applied Biological Materials
  • 11.2.7. OZ Biosciences
  • 11.2.8. Revvity
  • 11.2.9. Virongy
  • 11.2.10. BPS Bioscience
  • 11.2.11. komabiotech
  • 11.2.12. ABP Biosciences
  • 11.2.13. Merck KGaA (MilliporeSigma)
  • 11.2.14. Lonza Group
  • 11.2.15. Origene Technologies
  • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us